anaxirone has been researched along with Lung Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansen, F; Hansen, HH; Hansen, M; Lund, B | 1 |
| Banham, SW; Cunningham, D; Soukop, M | 1 |
| Arnold, H; Fiebig, HH; Henss, H; Klee, M; Peukert, M; Queisser, W; von Bültzingslöwen, F | 1 |
3 other study(ies) available for anaxirone and Lung Neoplasms
| Article | Year |
|---|---|
Phase II study of 1,2,4-triglycidylurazol (TGU) in previously untreated and treated patients with small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Small Cell; Drug Evaluation; Humans; Lung Neoplasms; Middle Aged; Prognosis; Triazoles | 1987 |
Small cell lung cancer: results of a phase II study of 1,2,4 triglycidylurazol.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Drug Evaluation; Humans; Leukocyte Count; Lung Neoplasms; Nausea; Platelet Count; Triazoles | 1986 |
Phase II trial of anaxirone in advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Triazoles | 1987 |